AAVEX
DEAD

Serial Number

79363339

Owner

Oxford Genetics Ltd

Filing Date

Dec 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AAVEX Trademark

Serial Number: 79363339

AAVEX is a trademark filed by Oxford Genetics Ltd on December 14, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Oxford Genetics Ltd (12 trademarks)

Medawar Centre,

Entity Type: 99

Trademark Details

Filing Date

December 14, 2022

Registration Date

Not Registered

Goods & Services

Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use

Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes

Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 9, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 8, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 8, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 8, 2024 ABN2
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2023 REPR